You are here:
Home
NICE Guidance
Conditions and diseases
Skin conditions
Diabetic foot
NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds
Medtech innovation briefing
Reference number:
MIB208
Published:
17 March 2020
Download (PDF)
Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Expert comments
Expert commentators
Development of this briefing
Regulatory information
NATROX is a CE-marked class 2b medical device.
Next page
Equality considerations
Previous page
The technology
Back to top